Teruhiko Yoshida

Lecturer

University of Tokyo

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Teruhiko Yoshida is a Lecturer at The University of Tokyo, Japan. His research primarily focuses on cellular metabolism, kidney pathology, and the effects of metabolic interventions on diseases, as reflected in his recent articles. Key areas of interest include the mechanisms of kidney fibrosis, the impact of specific genetic variants on health outcomes, and innovative approaches to treat recurrent ovarian cancer.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Yohei Komaru

Assistant Professor

University of Tokyo Hospital

JAPAN

View details

Kent Doi

University of Tokyo

JAPAN

View details

Ewa Krawczyk

Assistant Professor

Georgetown University Medical Center

UNITED STATES

View details

Ryota Inokuchi

Associate Professor

University of Tsukuba

JAPAN

View details

Matthew Hirschey

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Teruhiko Yoshida

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor–Induced Kidney Fibrosis

Supplementing Inosine to Blood Collection Tubes Adds a Glycolytic Inhibitory Effect

Renal and gastrointestinal complications following tosufloxacin therapy for suspected mycoplasma infection in a 10-year-old child

Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

NAD+ prevents chronic kidney disease by activating renal tubular metabolism

PKR activation-induced mitochondrial dysfunction in HIV-transgenic mice with nephropathy

Investigating quantitative histological characteristics in renal pathology using HistoLens

NAD deficiency contributes to progressive kidney disease in HIV nephropathy mice

Single-Cell Transcriptional Signatures of Glomerular Disease in Transgenic Mice with APOL1 Variants

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer.

NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease.

Solute Clearance Evaluation and Filter Clotting Prediction in Continuous Renal Replacement Therapy

Joint Associations of Pregnancy Complications and Postpartum Maternal Renal Biomarkers With Severe Cardiovascular Morbidities: A US Racially and Ethnically Diverse Prospective Birth Cohort Study

A novel ARPKD mouse model with near-complete deletion of the Polycystic Kidney and Hepatic Disease 1 (Pkhd1) genomic locus presents with multiple phenotypes but not renal cysts

Phenotypes of APOL1 High-Risk Status Subjects

Collaborators (5)

Yohei Komaru

Kent Doi

Ewa Krawczyk

Ryota Inokuchi

Matthew Hirschey

Make your next move.